Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer

NCT00199758 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

227

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG: cisplatin
DRUG: Gemcitabine
DRUG: Taxol

Sponsor

University Hospital, Limoges

Collaborators

[object Object]